Literature DB >> 20505664

Tolerizing allergic responses in the lung.

C M Lloyd1, J R Murdoch.   

Abstract

The absolute requirement of the pulmonary immune system is to limit the inflammatory consequences of inhaled infectious agents while maintaining tolerance to harmless aeroallergens. This tolerance is maintained by a complex network of cells and molecules interacting with lung stromal cells. However, in some individuals there is a breakdown in tolerance to particles such as pollens, animal dander, or dust, resulting in the development of allergic pathology. Emerging evidence suggests that this breakdown in tolerance is influenced by the genetic background of individuals as well as environmental considerations such as early exposure to respiratory pathogens. Further understanding of the mechanisms used by the pulmonary immune system to maintain tolerance might result in exploitation of novel avenues for therapy to treat the growing number of chronic asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505664      PMCID: PMC3381708          DOI: 10.1038/mi.2010.19

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  164 in total

1.  Short-term exposure to air pollution in a road tunnel enhances the asthmatic response to allergen.

Authors:  M Svartengren; V Strand; G Bylin; L Järup; G Pershagen
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

Review 2.  The Melbourne Asthma Study: 1964-1999.

Authors:  Peter D Phelan; Colin F Robertson; Anthony Olinsky
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

3.  By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation.

Authors:  Shyra J Gardai; Yi-Qun Xiao; Matthew Dickinson; Jerry A Nick; Dennis R Voelker; Kelly E Greene; Peter M Henson
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

4.  A population of murine gammadelta T cells that recognize an inducible MHC class Ib molecule.

Authors:  M P Crowley; A M Fahrer; N Baumgarth; J Hampl; I Gutgemann; L Teyton; Y Chien
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

Review 5.  Lung dendritic cells: targets for therapy in allergic disease.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.

Authors:  L Mascarell; V Lombardi; A Zimmer; A Louise; S Tourdot; L Van Overtvelt; P Moingeon
Journal:  Clin Exp Allergy       Date:  2009-08-20       Impact factor: 5.018

7.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

8.  Effect of diesel exhaust particles on allergic reactions and airway responsiveness in ovalbumin-sensitized brown Norway rats.

Authors:  Caroline C Dong; Xuejun J Yin; Jane Y C Ma; Lyndell Millecchia; Zhong-Xin Wu; Mark W Barger; Jenny R Roberts; James M Antonini; Richard D Dey; Joseph K H Ma
Journal:  Toxicol Sci       Date:  2005-08-17       Impact factor: 4.849

9.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

Review 10.  Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk.

Authors:  Emmanuel Scotet; Steven Nedellec; Marie-Claire Devilder; Sophie Allain; Marc Bonneville
Journal:  Front Biosci       Date:  2008-05-01
View more
  8 in total

1.  ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza.

Authors:  Andrea A Timothy; Ana Tokanovic; Kenneth J Snibson; Stirling J Edwards; Martin J Pearse; Jean-Pierre Y Scheerlinck; Philip Sutton
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Analysis of pulmonary dendritic cell maturation and migration during allergic airway inflammation.

Authors:  Rahul Kushwah; Jim Hu
Journal:  J Vis Exp       Date:  2012-07-23       Impact factor: 1.355

3.  Recurring BALB/c mouse lung inflammatory responses to episodic allergen exposure.

Authors:  S J Wilson; M J Harmer; R L Lee; H M Rigden; N M Doyon-Reale; K M Forman; X Gao; M W Lieh-Lai; D J P Bassett
Journal:  J Toxicol Environ Health A       Date:  2013

4.  CD8α⁺β⁻ and CD8α⁺β⁺ plasmacytoid dendritic cells induce Foxp3⁺ regulatory T cells and prevent the induction of airway hyper-reactivity.

Authors:  V Lombardi; A O Speak; J Kerzerho; N Szely; O Akbari
Journal:  Mucosal Immunol       Date:  2012-04-04       Impact factor: 7.313

Review 5.  The immunoregulatory and fibrotic roles of activin A in allergic asthma.

Authors:  C L Hardy; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-10       Impact factor: 5.018

6.  Allergy immunotherapy restores airway epithelial barrier dysfunction through suppressing IL-25 -induced endoplasmic reticulum stress in asthma.

Authors:  Xiefang Yuan; Junyi Wang; Yin Li; Xiang He; Bin Niu; Dehong Wu; Nan Lan; Xiaoyun Wang; Yun Zhang; Xi Dai; Xing Wang; Zhigang Liu; Guoping Li
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

Review 7.  Potential of immunoglobulin A to prevent allergic asthma.

Authors:  Anouk K Gloudemans; Bart N Lambrecht; Hermelijn H Smits
Journal:  Clin Dev Immunol       Date:  2013-04-11

Review 8.  New Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies.

Authors:  Juan L Paris; Paz de la Torre; Ana I Flores
Journal:  Pharmaceutics       Date:  2021-12-14       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.